DUCHENE MUSCULAR DYSTROPHY

Clinical trials for DUCHENE MUSCULAR DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new DUCHENE MUSCULAR DYSTROPHY trials appear

Sign up with your email to follow new studies for DUCHENE MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

FDA-Mandated 5-Year watch on new duchenne drug

Knowledge-focused Recruiting now

This study will observe 300 patients with Duchenne muscular dystrophy (DMD) who are already taking the approved drug givinostat as part of their regular care. Researchers will track patients for up to 5 years to understand the drug's real-world safety, especially regarding low pl…

Matched conditions: DUCHENE MUSCULAR DYSTROPHY

Sponsor: ITF Therapeutics LLC • Aim: Knowledge-focused

Last updated Mar 20, 2026 14:48 UTC

DUCHENE MUSCULAR DYSTROPHY

Get alerted when new DUCHENE MUSCULAR DYSTROPHY trials appear

FDA-Mandated 5-Year watch on new duchenne drug